Search for: "In Re: Watson v."
Results 321 - 340
of 364
Sort by Relevance
|
Sort by Date
2 Apr 2009, 1:00 pm
I think they're all honorable just like Worf. [read post]
23 Feb 2009, 2:27 am
See, e.g., Watson v. [read post]
13 Feb 2009, 7:00 am
(C.D.Cal. 2008) 2008 WL 4690536 Watson-Smith v. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re… [read post]
3 Feb 2009, 11:19 am
cost of re-training: $23,307 [read post]
16 Jan 2009, 5:00 am
: BMS v Hetero (GenericsWeb) India: Adding innovation to Ayurveda! [read post]
19 Dec 2008, 4:42 pm
In a poorly decided opinion, Van Horn v. [read post]
4 Dec 2008, 12:47 am
If you’re a solo or small firm practitioner, the cost is not too dear, but the confusion can be overwhelming. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol… [read post]
27 Sep 2008, 12:08 am
You can separately subscribe to the Pharma & Biotech edition of the Global week in Review by subscribing by email, or selecting ‘all posts’ or Pharma, Biotech & Chem' for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Canada/Africa: Apotex ships patented AIDS drugs to Rwanda under Canada's Access to Medicines Regime (CAMR) (Managing Intellectual Property) (GenericsWeb) Consolidation in the generic… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
7 Aug 2008, 10:09 am
Watson, 66 C.C.P.A. 107, 603 F.2d 192, 196-97 (1979). [read post]
25 Jun 2008, 6:15 pm
Supreme Court, June 18, 2008 Munaf v. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
6 Jun 2008, 6:49 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: YouTube – Prince demands removal of song from YouTube, Radiohead demand it is put back online: (Techdirt), (Electronic Frontier Foundation), (The Trademark Blog), Japan planning fair use provision: (Michael Geist), (Techdirt), (IP Justice), (Patry Copyright Blog), Judge rejects Yoko Ono’s request for preliminary injunction… [read post]
13 May 2008, 1:35 pm
Orsburn, No. 07-2584, 07-2585 Convictions for mail fraud are affirmed, but the sentences vacated and the case remanded for re-sentencing where the trial court applied the wrong Guidelines sentence when it concluded that embezzling money from the government fell under section 2C1.1 of the Guidelines which covers frauds that incl [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
21 Apr 2008, 11:52 am
Baze v. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
